Cinisello Balsamo, Italy

Maria Letizia Marchetti

This inventor holds 1 USPTO granted patent. Top assignee: Italfarmaco Spa. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Letizia Marchetti. Retrieved from https://idiyas.com/inventor/maria-letizia-marchetti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maria Letizia Marchetti: Innovator in Immunosuppressive Agents

Introduction

Maria Letizia Marchetti is a prominent inventor based in Cinisello Balsamo, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of immunosuppressive and anti-inflammatory agents. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.

Latest Patents

Maria Letizia Marchetti holds a patent for "Analogues of the active metabolite of leflunomide." This invention focuses on the analogues of the active metabolite of leflunomide and their use as immunosuppressive and/or anti-inflammatory agents. This patent highlights her innovative approach to addressing critical health issues.

Career Highlights

Throughout her career, Maria Letizia Marchetti has been associated with Italfarmaco Spa, a leading pharmaceutical company. Her role at Italfarmaco has allowed her to collaborate with other talented professionals in the industry, contributing to the development of groundbreaking therapies.

Collaborations

Maria has worked alongside esteemed colleagues such as Giorgio Bertolini and Mauro Biffi. These collaborations have enriched her research and have been instrumental in the successful development of her patented innovations.

Conclusion

Maria Letizia Marchetti is a remarkable inventor whose work in immunosuppressive agents has the potential to make a significant impact in the medical field. Her dedication to innovation and collaboration continues to drive advancements in pharmaceutical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…